| Value | ₹6.58 Cr |
|---|
NSE filing, NSE: RITEZONE. Summary written from the filing by ALFA Finder's alert engine.
Rite Zone Chemcon India Ltd: key numbers
- Share price
- ₹17.95
- Market cap
- ₹7.59 Cr
- Revenue (annual)
- ₹25.54 Cr
- Net profit (annual)
- ₹0.34 Cr
- P/E (TTM)
- 22.2×Sector 32.2×
- Promoter holding
- 41.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rite Zone Chemcon India Ltd
All →Rite Zone Chemcon India Preferential Issue
Rite Zone's EGM on November 23, 2026 seeks approval for a share swap and promoter preferential issue. Authorised capital rises to Rs 7.28 Crore.
- Value
- ₹6.58 Cr
Rite Zone Chemcon India Other Announcement
Rite Zone Chemcon is exempt from filing a Corporate Governance Report this quarter. As an SME-listed company, Regulation 15(2) waives these obligations.
Rite Zone Chemcon India Acquisition Worth ₹4.97 Cr
Rite Zone Chemcon's board approved acquiring 51% of Cleanux Green Solution via share swap for about INR 4.97 Crore. The board also approved preferential issues and an EGM on 23 November 2026.
- Value
- ₹4.97 Cr
Rite Zone Chemcon India Management Change
Rite Zone Chemcon India Limited announced the resignation of Mr. Chandrakant Shah as Chief Executive Officer, effective October 14, 2026.
Rite Zone Chemcon India Other Announcement
Rite Zone Chemcon India Limited has appointed M/s. SMNK & Company as the statutory auditor of the company for a term of 12 months.
- Execution
- 12 months
Rite Zone Chemcon India Annual General Meeting
Rite Zone Chemcon India Limited held its 11th Annual General Meeting on September 29, 2026. Shareholders considered financial statements, director appointments, and limits on borrowing and remuneration.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr